Evidence map›Paper›PMID 36150043›Full record

ArticleMicrobiology spectrum2022

Evolution of the

Li Li, Lia Di, Saymon Akther, Brian M Zeglis, Weigang Qiu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Outsmarting Pathogens with Antibody Engineering.Annual review of chemical and biomolecular engineering · 2023
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Li LiGraduate Center, City University of New York, New York, New York, USA.ORCID 0000-0002-5665-4746
Lia DiDepartment of Biological Sciences, Hunter Collegegrid.257167.0, City University of New York, New York, New York, USA.ORCID 0000-0003-1957-6475
Saymon AktherGraduate Center, City University of New York, New York, New York, USA.ORCID 0000-0002-9084-9379
Brian M ZeglisGraduate Center, City University of New York, New York, New York, USA.ORCID 0000-0002-9091-744X
Weigang QiuGraduate Center, City University of New York, New York, New York, USA.ORCID 0000-0003-4585-1872
The Graduate Center, CUNY · USCity University of New York · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Genomic & Host Drivers of Borrelia DiversificationR21AI139782 · NIAID · HUNTER COLLEGE · PI QIU, WEIGANG · 2018 to 2019
$429k
A PET Radiotracer for Diagnostic and Theranostics Imaging in Lyme DiseaseR21EB030275 · NIBIB · HUNTER COLLEGE · PI QIU, WEIGANG, ZEGLIS, BRIAN MATTHEW · 2020 to 2021
$429k
NCI NIH HHS P30 CA008748NIAID NIH HHS R21 AI139782NIBIB NIH HHS R21 EB030275
6 · The paper itself

Abstract

VlsE (variable major protein-like sequence, expressed) is an outer surface protein of the Lyme disease pathogen (

Indexed as

Borrelia burgdorferiLyme DiseaseAnimalsAntibodies, BacterialAntibodies, MonoclonalAntigenic VariationAntigens, BacterialBacterial ProteinsBiomarkersEpitopesHumansLipoproteinsMammalsMembrane ProteinsPeptidesRabbitsAntibodies, BacterialAntibodies, MonoclonalAntigens, BacterialBacterial ProteinsBiomarkersEpitopesLipoproteinsMembrane ProteinsPeptidesBorrelia burgdorferiC6 peptideLyme diseasemonoclonal antibodiesVlsE

Identifiers

PMID36150043
PMCPMC9604149
OpenAlexW4297021342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.